Potential new antibiotic for gonorrhoea as superbugs rise
Scientists have found the first new antibiotic treatment for the sexually transmitted infection gonorrhoea since the 1990s.
Experts discovered that gepotidacin, an antibiotic currently used to treat urinary tract infections, can also treat gonorrhoea.
It comes as experts warned that cases of gonorrhoea infections that are resistant to antibiotics are on the rise in England.
The UK Health Security Agency said in March that if the problem is not tackled, increased resistance could one day make the sexually transmitted infection (STI) 'untreatable'.
But a new study suggests that gepotidacin – which is taken as a pill – may help treat cases and could potentially help to alleviate the threat of treatment-resistant gonorrhoea infections.
A new study, published in The Lancet and presented at the ESCMID conference, saw experts compare gepotidacin with the current standard treatment for 'uncomplicated' gonorrhoea in 628 patients.
They found that the new pill is as effective as ceftriaxone with azithromycin for treating the infection.
It was also found to be able to treat strains of the infection that were resistant to current first-line treatments.
The authors said that 'gepotidacin demonstrated non-inferiority to ceftriaxone plus azithromycin' which offers a 'novel oral treatment option for uncomplicated urogenital gonorrhoea'.
'Gepotidacin is a novel oral antibacterial treatment with the potential to become an alternative option for the treatment of gonococcal infections,' they wrote.
Gonorrhoea can usually be treated effectively, although some cases can be resistant to the antibiotic ceftriaxone, which is the first line of treatment.
This means the bacteria that causes the infection has developed the ability to survive and multiply even when exposed to the antibiotic.
Some cases are also classed as 'extensively drug resistant' – or XDR – meaning the infection did not respond to ceftriaxone or the second line of treatment.
Figures from the UKHSA show that in the 15 months from January 2024 to March 2025, there were 17 cases of ceftriaxone-resistant gonorrhoea.
Thirteen were reported in 2024, with four cases in 2025 so far.
This is compared to 16 cases across 2022 and 2023.
In the same period, there were nine XDR cases reported – six in 2024 and three in 2025 so far.
This is compared to five cases between 2022 and 2023.
Ceftriaxone-resistant gonorrhoea was first detected in England in 2015 and 42 cases have since been reported.
The UKHSA said that there were about 54,965 gonorrhoea diagnoses at sexual health services in the first nine months of 2024 compared to more than 85,000 in the whole of 2023.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Measles holiday warning as cases rise in Europe
Families travelling abroad this summer on holiday or to visit relatives are being warned about the rise in measles cases in Europe and other regions. Measles infections in Europe are at a 25-year high, while cases are also surging in countries such as Pakistan and Nigeria. Childhood vaccination rates in the UK that offer protection against measles, mumps and rubella (MMR) are still a long way below the recommended 95% uptake, with the lowest regional rates found in London at just over 73% vaccinated. The UK Health Security Agency is warning holidaymakers to make sure they are up to date with their vaccinations and stress that it is never too late to get vaccinated. The UKHSA's latest data on measles infections shows that an outbreak is continuing in England. Some 109 cases were confirmed in April and 86 so far in May. These cases have mostly been in unvaccinated children aged 10 years and under. London has reported almost half of all cases in the past four weeks. Dr Vanessa Saliba, consultant epidemiologist at the UK Health Security Agency, says the rise in cases in England reflects what is happening abroad - and that's a concern as the summer holiday season gets going. "It's essential that everyone, particularly parents of young children, check all family members are up to date with two MMR doses, especially if you are travelling this summer for holidays or visiting family," Dr Saliba said. "Measles cases are picking up again in England and outbreaks are happening in Europe and many countries with close links to the UK." Measles spreads very easily and can be a nasty disease, leading to complications like ear and chest infections and inflammation of the brain with some children tragically ending up in hospital and suffering life-long consequences, Dr Saliba added. "Nobody wants this for their child and it's not something you want to experience when away on holiday." The decline in vaccination rates in the UK - particularly since the Covid pandemic - has been mirrored in other countries, especially in Europe. The World Health Organization and UNICEF reported 127,350 measles cases in the European Region in 2024 - double the number of cases reported during the previous year and the highest number since 1997. This year has seen outbreaks in several other European countries popular with UK holidaymakers, including France, Italy, Spain and Germany. The WHO has also reported that Romania, Pakistan, India, Thailand, Indonesia and Nigeria currently have among the largest number of measles cases worldwide. There has been a big push to improve MMR vaccination rates across the UK, but Dr Amanda Doyle, national director for primary care and community services at NHS England, says there is still a lot of work to do. "Too many babies and young children are still not protected against the diseases, which are contagious infections that spread very easily and can cause serious health problems. "MMR jabs are provided free as part of the NHS routine immunisation programme – and I would encourage all parents to act on invites or check vaccination records if they think they may have missed their child's vaccination." Health experts say that anyone, whatever their age, who has not had two doses of the MMR vaccine can contact their GP surgery to book an appointment and that it is never too late to catch up. Measles is a highly contagious disease which is spread by coughs and sneezes. Common symptoms include: high fever sore, red and watery eyes runny nose coughing sneezing Small white spots may appear inside the mouth. A blotchy red or brown rash usually appears after a few days, typically on the face and behind the ears, before spreading to the rest of the body. It can be harder to see on brown and black skin. Measles normally clears up within seven to 10 days. However, it can lead to pneumonia, meningitis, blindness and seizures. Babies and young children, pregnant women and those with a weakened immune system are at increased risk. Getting it while pregnant can lead to stillbirth, miscarriage or babies being born small. Measles can be fatal, but this is rare. Parents of baby with measles in vaccination plea 'Concerning' measles rise prompts warning Major MMR drive among teenagers and young adults
Yahoo
2 days ago
- Yahoo
What is driving a surge in COVID cases in India, other countries?
India has reported a sudden rise in COVID cases, starting from late May. Authorities said the number of active cases of the disease has surpassed 5,000. India is the latest of a number of countries to report an uptick in COVID cases this year as, more than five years after the virus was declared a global pandemic, waves of new strains continue to emerge. Here is what we know about the new variant of COVID and where it has spread: As of Thursday this week, there are 5,364 active cases in India, according to India's Ministry of Health and Family Welfare. Since January 1, more than 4,700 people have recovered from COVID in India, while 55 people have died from the virus. The main coronavirus variant causing a new spread of the disease is known as NB.1.8.1. Cases caused by this variant have been reported in the United Kingdom, the United States, Australia, Thailand, China and Hong Kong, among other countries. It is now the dominant variant in China and Hong Kong. A second variant, LF.7, is also responsible for some of the cases in India. The UK Health Security Agency (UKHSA) said it had recorded 13 cases of the NB.1.8.1 variant in England, with 'small numbers' detected across the UK. By late April, NB.1.8.1 comprised about 10.7 percent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 percent one month Omicron variant NB.1.8.1 was first detected in January this year. It is a 'recombinant' variant, which means it has arisen from the genetic mixing of two or more existing variants. On May 23, 2025, the WHO declared the NB.1.8.1 strain a 'variant under monitoring' (VUM). According to a 2023 definition by the WHO, a VUM is a variant which has undergone genetic changes that scientists believe could potentially affect the behaviour of the virus; early data suggests that this variant can grow faster or spread more easily than others, but this has not yet been confirmed. The evidence of the variant's impact on health, immunity or transmission is still unclear. While the NB.1.8.1 strain is still being researched, the evidence so far suggests that the strain may spread more easily, virologist Lara Herrero wrote for The Conversation on May 28. Researchers using lab-based models have found that of several variants tested, the new strain had the strongest ability to bind to human cell receptors. This suggests that the strain may 'infect cells more efficiently than earlier strains', Herrero wrote. 'It is more transmissible,' Subhash Verma, a professor of microbiology and immunology at the University of Nevada, Reno School of Medicine, told CBS News. Common symptoms of the NB.1.8.1 strain include a sore throat, cough, muscle aches, fever and nasal congestion. It can also cause gastrointestinal symptoms such as nausea and diarrhoea. Vaccines remain a powerful defence against COVID infections, severe sickness, hospitalisation and death, clinicians say. However, virologist Herrero wrote that besides spreading more easily, NB.1.8.1 may 'partially sidestep' immunity gained from the vaccines or prior infection. For now, health authorities say current COVID jabs are expected to be effective against this coronavirus variant and protect people from severe illness. Health experts worldwide say there is no evidence that the new strain of the coronavirus is more severe or deadly than any previous strain. However, it does appear to spread more easily. Since COVID spreads through airborne particles and droplets, the spread of the virus can be prevented by getting tested if symptoms show, wearing a mask and social distancing, clinicians have advised.
Yahoo
3 days ago
- Yahoo
Warning over measles risk during school holidays
Parents are being urged to make sure their children are vaccinated against measles ahead of the summer holidays as an outbreak continues to spread across the UK. Measles is one of the most contagious diseases in the world, but two doses of the MMR vaccine during childhood can offer lifelong protection. However, uptake of the vaccine in Britain is below recommended levels, and cases have been rising. Young children have the first dose of the vaccine when they are one year old and the second at between three years and four months and five years of age. There have been 420 measles cases in England so far this year, with 86 last month alone, figures from the UK Health Security Agency (UKHSA) reveal. Two thirds of the cases were in children under 10, and almost 40 per cent were in London. The capital has the lowest vaccination percentage in the country, with more than a quarter of the population going without full protection. Officials are concerned that the infection, which can lead to serious complications, spreads easily through the air via sneezes, coughs and exhalations. They said it could see an uptick when schools break up for the summer and children mingle during the holidays. Measles has an estimated 'R' number of around 18, which means that, on average, a single infected person passes the infection on to 18 others. Covid has a natural 'R' number of about three. Dr Vanessa Saliba, a consultant epidemiologist at UKHSA, said: 'It's essential that everyone, particularly parents of young children, check all family members are up to date with two MMR doses, especially if you are travelling this summer for holidays or visiting family. 'Measles cases are picking up again in England, and outbreaks are happening in Europe and many countries with close links to the UK. 'Measles spreads very easily and can be a nasty disease, leading to complications like ear and chest infections and inflammation of the brain, with some children tragically ending up in hospital and suffering life-long consequences. Nobody wants this for their child, and it's not something you want to experience when away on holiday.' People who have the two doses of the MMR vaccine, which are safe and effective, are not only protecting themselves but also helping protect others who are unvaccinated, such as young babies. Health officials said parents could check their child's 'red book', a national record given to parents or carers to document a child's health and development, to see if they are fully protected. Adults can check their vaccination status by contacting their GP or checking in the NHS app, although not everyone's complete immunisation data is live on the app. UKHSA said that cases in Europe had reached their highest level in almost three decades last year. A global increase in measles has led the agency to say it is concerned that this could mean people bring back the contagious disease to England after travelling over the summer. There were more than 127,000 cases of measles in Europe last year, according to global health leaders, the highest number since 1997. So far this year, outbreaks have been documented in France, Italy, Spain and Germany. Romania, Pakistan, India, Thailand, Indonesia and Nigeria currently have among the largest number of measles cases worldwide, according to a recent report by the World Health Organisation. Dr Amanda Doyle, the national director for primary care and community services at NHS England, said: 'The recent increase in cases seen in England and Europe should act as an important reminder to ensure your child is protected. 'Too many babies and young children are still not protected against the diseases, which are contagious infections that spread very easily and can cause serious health problems. 'MMR jabs are provided free as part of the NHS routine immunisation programme, and I would encourage all parents to act on invites or check vaccination records if they think they may have missed their child's vaccination.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
